KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Merck (MRK) Long-Term Debt Issuances (2016 - 2025)

Merck (MRK) has disclosed Long-Term Debt Issuances for 11 consecutive years, with $7.9 billion as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Issuances changed N/A to $7.9 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $13.9 billion, a 173587.5% increase, with the full-year FY2025 number at $13.9 billion, up 285.66% from a year prior.
  • Long-Term Debt Issuances was $7.9 billion for Q4 2025 at Merck, up from $6.0 billion in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $7.9 billion in Q4 2021 to a low of -$7.0 million in Q3 2023.
  • A 4-year average of $4.4 billion and a median of $6.0 billion in 2025 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: surged 85.71% in 2024, then soared 596300.0% in 2025.
  • Merck's Long-Term Debt Issuances stood at $7.9 billion in 2021, then plummeted by 100.09% to -$7.0 million in 2023, then skyrocketed by 85.71% to -$1.0 million in 2024, then skyrocketed by 791900.0% to $7.9 billion in 2025.
  • Per Business Quant, the three most recent readings for MRK's Long-Term Debt Issuances are $7.9 billion (Q4 2025), $6.0 billion (Q3 2025), and -$1.0 million (Q3 2024).